XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments (Tables)
3 Months Ended
Mar. 31, 2022
Receivables [Abstract]  
Loans and Allowance for Loan Losses
The composition of loans at amortized cost basis broken out by class of financing receivable at March 31, 2022 and December 31, 2021 is presented in the following table:
(Dollars in millions)March 31, 2022December 31, 2021
Global fund banking$39,344 $37,958 
Investor dependent:
Early stage1,707 1,593 
Growth stage4,032 3,951 
Total investor dependent5,739 5,544 
Cash flow dependent - SLBO1,826 1,798 
Innovation C&I7,260 6,673 
Private bank (4)9,235 8,743 
CRE (4)2,595 2,670 
Premium wine (4)997 985 
Other C&I1,175 1,257 
Other (4)319 317 
PPP175 331 
Total loans (1) (2) (3)$68,665 $66,276 
ACL(421)(422)
Net loans$68,244 $65,854 
(1)    Total loans at amortized cost is net of unearned income, deferred fees and costs, and net unamortized premiums and discounts of $207 million and $250 million at March 31, 2022 and December 31, 2021, respectively.
(2)     Included within our total loan portfolio are credit card loans of $627 million and $583 million at March 31, 2022 and December 31, 2021, respectively.
(3)     Included within our total loan portfolio are construction loans of $384 million and $367 million at March 31, 2022 and December 31, 2021, respectively.
(4)     Of our total loans, the table below includes those secured by real estate at amortized cost at March 31, 2022 and December 31, 2021 and were comprised of the following:
(Dollars in millions)March 31, 2022December 31, 2021
Real estate secured loans:
Private bank:
Loans for personal residence$7,302 $6,939 
Loans to eligible employees463 455 
Home equity lines of credit130 130 
Other134 135 
Total private bank loans secured by real estate$8,029 $7,659 
CRE:
Multifamily and residential investment980 1,021 
Retail511 524 
Office and medical480 499 
Manufacturing, industrial and warehouse353 336 
Hospitality141 142 
Other130 148 
Total CRE loans secured by real estate$2,595 $2,670 
Premium wine794 793 
Other348 334 
Total real estate secured loans$11,766 $11,456 
Credit Quality Indicators, Broken out by Portfolio Segment and Class of Financing Receivables
The following tables summarize the credit quality indicators, broken out by class of financing receivable and vintage year, as of March 31, 2022 and December 31, 2021:

Term Loans by Origination Year
March 31, 2022 (Dollars in millions)20222021202020192018PriorRevolving LoansRevolving Loans Converted to Term LoansUnallocated (1)Total
Global fund banking:
Risk rating:
Pass $292 $294 $122 $33 $$12 $38,587 $— $— $39,344 
Criticized— — — — — — — — — — 
Nonperforming— — — — — — — — — — 
Total global fund banking$292 $294 $122 $33 $$12 $38,587 $— $— $39,344 
Investor dependent:
Early stage:
Risk rating:
Pass $236 $769 $195 $75 $14 $$194 $— $— $1,485 
Criticized81 69 20 32 — — 217 
Nonperforming— — — — — 
Total early stage$244 $852 $265 $95 $19 $$227 $— $— $1,707 
Growth stage:
Risk rating:
Pass $538 $1,878 $730 $144 $58 $12 $328 $$— $3,692 
Criticized18 172 78 19 45 — — 337 
Nonperforming— — — — — — 
Total growth stage$556 $2,051 $808 $164 $61 $15 $373 $$— $4,032 
Total investor dependent$800 $2,903 $1,073 $259 $80 $20 $600 $$— $5,739 
Cash flow dependent - SLBO:
Risk rating:
Pass $289 $753 $298 $225 $68 $65 $29 $— $— $1,727 
Criticized— — 16 26 13 — — 67 
Nonperforming— — — 11 — — 32 
Total cash flow dependent - SLBO$289 $753 $314 $240 $103 $85 $42 $— $— $1,826 
Innovation C&I
Risk rating:
Pass $673 $2,115 $977 $248 $76 $57 $2,635 $— $— $6,781 
Criticized106 119 35 12 — 206 — — 479 
Nonperforming— — — — — — — — — — 
Total innovation C&I$674 $2,221 $1,096 $283 $88 $57 $2,841 $— $— $7,260 
Private bank:
Risk rating:
Pass $771 $2,929 $1,932 $1,044 $485 $1,248 $782 $$— $9,199 
Criticized— — — — 11 — — 15 
Nonperforming— — — — 21 
Total private bank$771 $2,929 $1,933 $1,048 $492 $1,268 $786 $$— $9,235 
CRE
Risk rating:
Pass $91 $323 $212 $310 $125 $1,007 $88 $$— $2,158 
Criticized39 117 37 205 18 12 — 432 
Nonperforming— — — — — — — — 
Total CRE$93 $325 $251 $432 $162 $1,212 $106 $14 $— $2,595 
Premium wine:
Risk rating:
Pass $28 $217 $112 $144 $68 $206 $140 $34 $— $949 
Criticized— 11 10 10 — — 48 
Nonperforming— — — — — — — — — — 
Total premium wine$28 $218 $119 $155 $77 $216 $150 $34 $— $997 
Other C&I
Risk rating:
Pass $$173 $170 $76 $93 $322 $276 $12 $— $1,128 
Criticized— 10 — 43 
Nonperforming— — — — — 
Total other C&I$$177 $177 $83 $101 $328 $287 $16 $— $1,175 
Other:
Risk rating:
Pass $$82 $157 $53 $20 $14 $10 $— $(36)$305 
Criticized— — 11 — — — — 14 
Nonperforming— — — — — — — — — — 
Total other$$82 $168 $54 $20 $16 $10 $— $(36)$319 
PPP:
Risk rating:
Pass $— $134 $25 $— $— $— $— $— $(3)$156 
Criticized— 12 — — — — — — 19 
Nonperforming— — — — — — — — — — 
Total PPP$— $146 $32 $— $— $— $— $— $(3)$175 
Total loans$2,958 $10,048 $5,285 $2,587 $1,127 $3,214 $43,409 $76 $(39)$68,665 
(1)    These amounts consist of fees and clearing items that have not yet been allocated at the loan level.

Term Loans by Origination Year
December 31, 2021 (Dollars in millions)20212020201920182017PriorRevolving LoansRevolving Loans Converted to Term LoansUnallocated (1)Total
Global fund banking:
Risk rating:
Pass $764 $115 $36 $$$$36,955 $— $— $37,888 
Criticized50 18 — — — — — 70 
Nonperforming— — — — — — — — — — 
Total global fund banking$814 $133 $36 $$$$36,956 $— $— $37,958 
Investor dependent:
Early stage:
Risk rating:
Pass $754 $287 $122 $26 $$$171 $— $— $1,367 
Criticized64 87 30 — — 29 — — 215 
Nonperforming— — — — — 11 
Total early stage$820 $379 $155 $31 $$$201 $— $— $1,593 
Growth stage:
Risk rating:
Pass $2,072 $910 $265 $78 $14 $$286 $$— $3,631 
Criticized159 85 27 — 34 — — 314 
Nonperforming— — — — — 
Total growth stage$2,233 $995 $293 $86 $17 $$321 $$— $3,951 
Total investor dependent$3,053 $1,374 $448 $117 $23 $$522 $$— $5,544 
Cash flow dependent - SLBO:
Risk rating:
Pass $875 $384 $252 $72 $76 $$35 $— $— $1,696 
Criticized— — 20 25 — 13 10 — — 68 
Nonperforming— — 12 10 — — — 34 
Total cash flow dependent - SLBO$875 $384 $284 $107 $83 $15 $50 $— $— $1,798 
Innovation C&I:
Risk rating:
Pass $2,230 $1,058 $288 $123 $58 $— $2,411 $— $— $6,168 
Criticized64 130 62 12 — — 236 — — 504 
Nonperforming— — — — — — — — 
Total Innovation C&I$2,294 $1,188 $350 $135 $58 $— $2,648 $— $— $6,673 
Private bank:
Risk rating:
Pass $2,952 $2,015 $1,122 $520 $432 $952 $705 $$— $8,706 
Criticized— — — — — 16 
Nonperforming— — — — — 21 
Total private bank$2,952 $2,015 $1,126 $529 $434 $969 $710 $$— $8,743 
CRE
Risk rating:
Pass$326 $215 $344 $155 $236 $868 $110 $$— $2,256 
Criticized39 114 37 47 139 18 12 — 409 
Nonperforming— — — — — — — — 
Total CRE$329 $254 $463 $192 $283 $1,007 $128 $14 $— $2,670 
Premium wine:
Risk rating:
Pass $217 $112 $156 $69 $71 $162 $125 $34 $— $946 
Criticized11 — — 11 — — 39 
Nonperforming— — — — — — — — — — 
Total Premium wine$218 $119 $167 $78 $71 $162 $136 $34 $— $985 
Other C&I
Risk rating:
Pass$181 $175 $82 $86 $28 $301 $350 $11 $— $1,214 
Criticized— — 39 
Nonperforming— — — — — — 
Total other C&I$186 $181 $88 $95 $30 $302 $359 $16 $— $1,257 
Other:
Risk rating:
Pass $61 $144 $82 $20 $14 $— $$— $(21)$307 
Criticized— — — — — — 10 
Nonperforming— — — — — — — — — — 
Total other$61 $151 $83 $20 $16 $— $$— $(21)$317 
PPP:
Risk rating:
Pass $226 $72 $— $— $— $— $— $— $— $298 
Criticized22 — — — — — — — 31 
Nonperforming— — — — — — — — 
Total PPP$250 $81 $— $— $— $— $— $— $— $331 
Total loans$11,032 $5,880 $3,045 $1,279 $1,006 $2,462 $41,516 $77 $(21)$66,276 
(1)    These amounts consist of fees and clearing items that have not yet been allocated at the loan level.
Activity in Allowance for Loan Losses Broken out by Portfolio Segment
The following tables summarize the activity relating to our ACL for loans for the three months ended March 31, 2022 and 2021, broken out by portfolio segment:
Three months ended March 31, 2022Beginning Balance December 31, 2021Charge-offsRecoveries Provision (Reduction) for Credit Loss for LoansForeign Currency Translation AdjustmentsEnding Balance March 31, 2022
(Dollars in millions)
Global fund banking$67 $— $— $(1)$— $66 
Investor dependent146 (17)11 — 148 
Cash flow dependent and innovation C&I118 — — (3)— 115 
Private bank33 — — 37 
CRE36 — — (2)— 34 
Other C&I14 (1)— (1)— 12 
Premium wine and other— — (1)
Total ACL$422 $(18)$10 $$(1)$421 
Three months ended March 31, 2021Beginning Balance December 31, 2020Charge-offsRecoveriesProvision (Reduction) for Credit Loss for LoansEnding Balance March 31, 2021
(Dollars in millions)
Global fund banking$46 $(80)$— $94 $60 
Investor dependent213 (14)(36)168 
Cash flow dependent and innovation C&I125 — — (13)112 
Private Bank53 — — (9)44 
Premium wine and other(1)— — 
PPP— — (2)— 
Total ACL$448 $(95)$$34 $392 
The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three months ended March 31, 2022 and 2021:
 Three months ended March 31,
(Dollars in millions)20222021
ACL: unfunded credit commitments, beginning balance$171 $121 
Provision for (reduction in) credit losses(16)
ACL: unfunded credit commitments, ending balance (1)$175 $105 
(1)The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.
Financing Receivable, Past Due
The following table summarizes the aging of our loans broken out by class of financing receivable as of March 31, 2022 and December 31, 2021:
(Dollars in millions)30 - 59
  Days Past  
Due
60 - 89
  Days Past  
Due
Equal to or Greater
Than 90
  Days Past  
Due
  Total Past  
Due
Current  Total   Loans Past Due
90 Days or
More Still
Accruing
Interest
March 31, 2022:
Global fund banking$— $— $— $— $39,344 $39,344 $— 
Investor dependent:
Early stage1,703 1,707 — 
Growth stage33 — — 33 3,999 4,032 — 
Total investor dependent35 37 5,702 5,739 — 
Cash flow dependent - SLBO— — — — 1,826 1,826 — 
Innovation C&I— 7,252 7,260 — 
Private bank24 11 36 9,199 9,235 — 
CRE— — 2,594 2,595 — 
Premium wine— — — — 997 997 — 
Other C&I12 — 13 1,162 1,175 — 
Other— — — — 319 319 — 
PPP— — 172 175 
Total loans$79 $$16 $98 $68,567 $68,665 $
December 31, 2021:
Global fund banking$— $— $— $— $37,958 $37,958 $— 
Investor dependent:
Early stage— 11 1,582 1,593 — 
Growth stage16 — — 16 3,935 3,951 — 
Total investor dependent22 — 27 5,517 5,544 — 
Cash flow dependent - SLBO— — — — 1,798 1,798 — 
Innovation C&I— 14 6,659 6,673 
Private bank28 12 41 8,702 8,743 — 
CRE— — 2,669 2,670 — 
Premium wine— — 982 985 — 
Other C&I1,253 1,257 — 
Other— — — — 317 317 — 
PPP— — 330 331 — 
Total loans$63 $$20 $91 $66,185 $66,276 $
Financing Receivable, Nonaccrual
The following table summarizes our nonaccrual loans with no allowance for credit loss at March 31, 2022 and December 31, 2021:
March 31, 2022December 31, 2021
(Dollars in millions)Nonaccrual LoansNonaccrual Loans with no Allowance for Credit LossNonaccrual Loans Nonaccrual Loans with no Allowance for Credit Loss
Investor dependent:
Early stage$$$11 $— 
Growth stage— — 
Total investor dependent17 — 
Cash flow dependent - SLBO32 — 34 — 
Innovation C&I— — 
Private bank21 13 21 
CRE— 
Other C&I— 
PPP— — — 
Total nonaccrual loans$70 $20 $84 $
Summary of Loans Modified in Troubled Debt Restructurings ("TDRs") by Risk-based Segment
The following table summarizes our loans modified in TDRs, broken out by class of financing receivable at March 31, 2022 and December 31, 2021:
(Dollars in millions)March 31, 2022December 31, 2021
Loans modified in TDRs:
Investor dependent:
Early stage$$12 
Growth stage
Total investor dependent15 
Cash flow dependent - SLBO33 34 
Private bank18 12 
CRE33 33 
Other C&I
Total loans modified in TDRs$92 $96 
Recorded Investment in Loans Modified in TDRs
The following table summarizes the recorded investment in loans modified in TDRs, broken out by class of financing receivable, for modifications made during the three months ended March 31, 2022 and 2021:
 Three months ended March 31,
(Dollars in millions)20222021
Loans modified in TDRs during the period:
Investor dependent:
Growth stage$— 
Total investor dependent— 
Cash flow dependent - SLBO— 18 
Innovation C&I— 
Private bank
Other C&I— 
Total loans modified in TDRs during the period (1)$$24 
(1)There were $5 million partial charge-offs for the three months ended March 31, 2022 compared to $2 million of partial charge-offs for the three months ended March 31, 2021.
Activity Relating to ACL for Unfunded Credit Commitments
The following tables summarize the activity relating to our ACL for loans for the three months ended March 31, 2022 and 2021, broken out by portfolio segment:
Three months ended March 31, 2022Beginning Balance December 31, 2021Charge-offsRecoveries Provision (Reduction) for Credit Loss for LoansForeign Currency Translation AdjustmentsEnding Balance March 31, 2022
(Dollars in millions)
Global fund banking$67 $— $— $(1)$— $66 
Investor dependent146 (17)11 — 148 
Cash flow dependent and innovation C&I118 — — (3)— 115 
Private bank33 — — 37 
CRE36 — — (2)— 34 
Other C&I14 (1)— (1)— 12 
Premium wine and other— — (1)
Total ACL$422 $(18)$10 $$(1)$421 
Three months ended March 31, 2021Beginning Balance December 31, 2020Charge-offsRecoveriesProvision (Reduction) for Credit Loss for LoansEnding Balance March 31, 2021
(Dollars in millions)
Global fund banking$46 $(80)$— $94 $60 
Investor dependent213 (14)(36)168 
Cash flow dependent and innovation C&I125 — — (13)112 
Private Bank53 — — (9)44 
Premium wine and other(1)— — 
PPP— — (2)— 
Total ACL$448 $(95)$$34 $392 
The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three months ended March 31, 2022 and 2021:
 Three months ended March 31,
(Dollars in millions)20222021
ACL: unfunded credit commitments, beginning balance$171 $121 
Provision for (reduction in) credit losses(16)
ACL: unfunded credit commitments, ending balance (1)$175 $105 
(1)The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.